Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Mitochondria plays an important role in signal transduction in innate immune pathways

Mitochondria are primarily known as the powerhouse of the cell. However, these cellular organelles are required not only for providing energy: Professor Konstanze Winklhofer and her group at the Faculty of Medicine at Ruhr University Bochum, Germany, recently discovered that mitochondria play an important role in signal transduction in innate immune pathways.

17 Nov 2022

Utilizing marine sources to extract DHA to treat Alzheimer’s

The anti-neurodegenerative effects of docosahexaenoic acid (DHA) and DHA-rich phospholipids (DH-PL) derived from fisheries and aquaculture byproducts.

15 Nov 2022

How air pollution affects the central nervous system over time

An article published in the journal Toxics describes how air pollutants adversely impact the human nervous system.

13 Nov 2022

Focused ultrasound treatment offers long-term relief for patients with essential tremor

A scalpel-free, high-tech form of brain surgery pioneered at UVA Health offers long-term relief for patients with essential tremor, a common movement disorder, a five-year review shows.

10 Nov 2022

New approach can help design shorter, more powerful trials to assess Parkinson’s drugs

Testing whether a new drug impacts the progression of Parkinson's disease takes years, in part because the disease often advances so slowly.

10 Nov 2022

Characteristics of patients' drawing process can determine the type of dementia, study finds

The two most common neurodegenerative dementias are Alzheimer's disease (AD) and dementia with Lewy bodies (DLB). There is often an overlap of symptoms across these two diseases, which can make diagnoses difficult.

9 Nov 2022

Understanding the gut-brain connection in metabolic and neurological disorders

The community of microorganisms living in the human gut, known as the gut microbiome, is increasingly recognized as playing a pivotal role in metabolic conditions such as obesity and neurological diseases including Parkinson's disease.

9 Nov 2022

OHSU discovery could suggest new avenues to treat symptoms of Parkinson's disease

Researchers at Oregon Health & Science University have discovered that the neurotransmitter adenosine effectively acts as a brake to dopamine, another well-known neurotransmitter involved in motor control.

9 Nov 2022

Researchers decipher key mechanism in the pathogenesis of juvenile Parkinson's

Parkinson's disease affects 3% of population over 65 years old, and the average age of onset is 60. Regarding juvenile Parkinson, which represents the of all Parkison's cases, the disease begins before 40 years old.

8 Nov 2022

Study reveals the extent of aggression towards caregivers in Parkinson's disease

Caregivers already dealing with the stress of looking after a loved one diagnosed with Parkinson's disease often have another concern to contend with -; aggressive behavior directed toward them from the Parkinson's patient.

7 Nov 2022

SARS-CoV-2 activates NLRP3 inflammasome

Researchers assessed the role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the NLR family pyrin domain containing 3 (NLRP3) inflammasome activation.

7 Nov 2022

New insights into the dynamic inner world of the human immune system

As researchers glean new insights into the dynamic inner world of the human immune system, it has become increasingly clear that mitochondria are critical regulators of how our bodies respond to disease.

3 Nov 2022

Moderate to heavy drinking could increase the risk of stroke in young adults

People in their 20s and 30s who drink moderate to heavy amounts of alcohol may be more likely to have a stroke as young adults than people who drink low amounts or no alcohol, according to a study published in the November 2, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

2 Nov 2022

Researchers corroborate the importance of exercise for cognitive function

Accumulating evidence finds that exercise can improve brain function and delay or prevent the onset of neurodegenerative diseases such as Alzheimer's and Parkinson's disease.

2 Nov 2022

People who had COVID-19 are more vulnerable to developing neurological symptoms

Research led by The University of Queensland has found COVID-19 activates the same inflammatory response in the brain as Parkinson's disease.

1 Nov 2022

Appel Alzheimer's Disease Research Institute Symposium reveals new developments in dementia research

The 10th annual Appel Alzheimer's Disease Research Institute Symposium brought fascinating reports of progress in understanding Alzheimer's and related neurodegenerative diseases.

28 Oct 2022

Study provides new insights into genetic form of frontotemporal dementia

Dementia encompasses a range of neurodegenerative conditions that lead to memory loss and cognitive deficiencies and affect some 55 million people worldwide.

28 Oct 2022

New studies point to a broadly applicable treatment for neurodegenerative diseases

Two new studies from Washington University School of Medicine in St. Louis support development of a broadly applicable treatment for neurodegenerative diseases that targets a molecule that serves as the central executioner in the death of axons, the wiring of the nervous system.

26 Oct 2022

Higher exposure to particulate matter may be associated with increased dementia risk

Higher exposure to a certain type of traffic-related air pollution called particulate matter may be linked to an increased risk of dementia, according to a meta-analysis published in the October 26, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

26 Oct 2022

Subarachnoid hemorrhage incidence is higher and increasing in Black patients, study says

Rates of one type of stroke called subarachnoid hemorrhage have increased in older people and men in recent years, and such strokes occur in Black people at a disproportionately higher rate compared to people of other races and ethnicities, according to a study published in the October 26, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

26 Oct 2022

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Mitochondria plays an important role in signal transduction in innate immune pathways

Utilizing marine sources to extract DHA to treat Alzheimer’s

How air pollution affects the central nervous system over time

Focused ultrasound treatment offers long-term relief for patients with essential tremor

New approach can help design shorter, more powerful trials to assess Parkinson’s drugs

Characteristics of patients' drawing process can determine the type of dementia, study finds

Understanding the gut-brain connection in metabolic and neurological disorders

OHSU discovery could suggest new avenues to treat symptoms of Parkinson's disease

Researchers decipher key mechanism in the pathogenesis of juvenile Parkinson's

Study reveals the extent of aggression towards caregivers in Parkinson's disease

SARS-CoV-2 activates NLRP3 inflammasome

New insights into the dynamic inner world of the human immune system

Moderate to heavy drinking could increase the risk of stroke in young adults

Researchers corroborate the importance of exercise for cognitive function

People who had COVID-19 are more vulnerable to developing neurological symptoms

Appel Alzheimer's Disease Research Institute Symposium reveals new developments in dementia research

Study provides new insights into genetic form of frontotemporal dementia

New studies point to a broadly applicable treatment for neurodegenerative diseases

Higher exposure to particulate matter may be associated with increased dementia risk

Subarachnoid hemorrhage incidence is higher and increasing in Black patients, study says

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in